pulmonary drugs market

Global Pulmonary Drugs Market Analysis 2016-2020 and Forecast 2021-2026

  • Published Date: 2021-04-17
  • Report ID: 96410
  • Pages: 104
  • Format: prudent report format

Snapshot

The global Pulmonary Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Pulmonary Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Inhaled Corticosteroids (ICS)
Long-Acting Beta2-Agonists (LABA)
Antihistamine
Vasodilators
Short-Acting Beta2-Agonists (SABA)
Anticholinergics
Combination Drugs
MAbs
Enzymes
Antibiotics & Antileukotrienes

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
AstraZeneca plc
Bayer AG
Teva Pharmaceutical Industries Ltd
Actelion Pharmaceuticals, Inc.
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Novartis AG
GlaxoSmithKline plc
Sunovion Pharmaceuticals

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Asthma & COPD
Allergic Rhinitis
Pulmonary Arterial Hypertension
Cystic Fibrosis

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
Table of Contents
1 Industry Overview
1.1 Pulmonary Drugs Industry
Figure Pulmonary Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Pulmonary Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Pulmonary Drugs
1.2.2 Downstream
Table Application Segment of Pulmonary Drugs
Table Global Pulmonary Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Pulmonary Drugs Market by Type
3.1 By Type
3.1.1 Inhaled Corticosteroids (ICS)
Table Major Company List of Inhaled Corticosteroids (ICS)
3.1.2 Long-Acting Beta2-Agonists (LABA)
Table Major Company List of Long-Acting Beta2-Agonists (LABA)
3.1.3 Antihistamine
Table Major Company List of Antihistamine
3.1.4 Vasodilators
Table Major Company List of Vasodilators
3.1.5 Short-Acting Beta2-Agonists (SABA)
Table Major Company List of Short-Acting Beta2-Agonists (SABA)
3.1.6 Anticholinergics
Table Major Company List of Anticholinergics
3.1.7 Combination Drugs
Table Major Company List of Combination Drugs
3.1.8 MAbs
Table Major Company List of MAbs
3.1.9 Enzymes
Table Major Company List of Enzymes
3.1.10 Antibiotics & Antileukotrienes
Table Major Company List of Antibiotics & Antileukotrienes
3.2 Market Size
Table Global Pulmonary Drugs Market 2016-2020, by Type, in USD Million
Figure Global Pulmonary Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Pulmonary Drugs Market 2016-2020, by Type, in Volume
Figure Global Pulmonary Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Pulmonary Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Pulmonary Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 AstraZeneca plc (Company Profile, Sales Data etc.)
4.1.1 AstraZeneca plc Profile
Table AstraZeneca plc Overview List
4.1.2 AstraZeneca plc Products & Services
4.1.3 AstraZeneca plc Business Operation Conditions
Table Business Operation of AstraZeneca plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Bayer AG (Company Profile, Sales Data etc.)
4.2.1 Bayer AG Profile
Table Bayer AG Overview List
4.2.2 Bayer AG Products & Services
4.2.3 Bayer AG Business Operation Conditions
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Teva Pharmaceutical Industries Ltd (Company Profile, Sales Data etc.)
4.3.1 Teva Pharmaceutical Industries Ltd Profile
Table Teva Pharmaceutical Industries Ltd Overview List
4.3.2 Teva Pharmaceutical Industries Ltd Products & Services
4.3.3 Teva Pharmaceutical Industries Ltd Business Operation Conditions
Table Business Operation of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Actelion Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.4.1 Actelion Pharmaceuticals, Inc. Profile
Table Actelion Pharmaceuticals, Inc. Overview List
4.4.2 Actelion Pharmaceuticals, Inc. Products & Services
4.4.3 Actelion Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Actelion Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.)
4.5.1 Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Overview List
4.5.2 Boehringer Ingelheim GmbH Products & Services
4.5.3 Boehringer Ingelheim GmbH Business Operation Conditions
Table Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 F. Hoffmann-La Roche Ltd. (Company Profile, Sales Data etc.)
4.6.1 F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Overview List
4.6.2 F. Hoffmann-La Roche Ltd. Products & Services
4.6.3 F. Hoffmann-La Roche Ltd. Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Merck & Co., Inc. (Company Profile, Sales Data etc.)
4.7.1 Merck & Co., Inc. Profile
Table Merck & Co., Inc. Overview List
4.7.2 Merck & Co., Inc. Products & Services
4.7.3 Merck & Co., Inc. Business Operation Conditions
Table Business Operation of Merck & Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Novartis AG (Company Profile, Sales Data etc.)
4.8.1 Novartis AG Profile
Table Novartis AG Overview List
4.8.2 Novartis AG Products & Services
4.8.3 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 GlaxoSmithKline plc (Company Profile, Sales Data etc.)
4.9.1 GlaxoSmithKline plc Profile
Table GlaxoSmithKline plc Overview List
4.9.2 GlaxoSmithKline plc Products & Services
4.9.3 GlaxoSmithKline plc Business Operation Conditions
Table Business Operation of GlaxoSmithKline plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Sunovion Pharmaceuticals (Company Profile, Sales Data etc.)
4.10.1 Sunovion Pharmaceuticals Profile
Table Sunovion Pharmaceuticals Overview List
4.10.2 Sunovion Pharmaceuticals Products & Services
4.10.3 Sunovion Pharmaceuticals Business Operation Conditions
Table Business Operation of Sunovion Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Pulmonary Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Pulmonary Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Pulmonary Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Pulmonary Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Pulmonary Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Pulmonary Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Pulmonary Drugs Market Concentration, in 2020
Figure Europe Pulmonary Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Pulmonary Drugs MMarket Concentration, in 2020
Figure South America Pulmonary Drugs Market Concentration, in 2020
Figure Middle East & Africa Pulmonary Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Asthma & COPD
Figure Pulmonary Drugs Demand in Asthma & COPD, 2016-2020, in USD Million
Figure Pulmonary Drugs Demand in Asthma & COPD, 2016-2020, in Volume
6.1.2 Demand in Allergic Rhinitis
Figure Pulmonary Drugs Demand in Allergic Rhinitis, 2016-2020, in USD Million
Figure Pulmonary Drugs Demand in Allergic Rhinitis, 2016-2020, in Volume
6.1.3 Demand in Pulmonary Arterial Hypertension
Figure Pulmonary Drugs Demand in Pulmonary Arterial Hypertension, 2016-2020, in USD Million
Figure Pulmonary Drugs Demand in Pulmonary Arterial Hypertension, 2016-2020, in Volume
6.1.4 Demand in Cystic Fibrosis
Figure Pulmonary Drugs Demand in Cystic Fibrosis, 2016-2020, in USD Million
Figure Pulmonary Drugs Demand in Cystic Fibrosis, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Pulmonary Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Pulmonary Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Pulmonary Drugs Market Share in 2026, by Application, in USD Million
Table Pulmonary Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Pulmonary Drugs Market Growth 2021-2026, by Application, in Volume
Table Pulmonary Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Pulmonary Drugs Production 2016-2020, by Region, in USD Million
Table Pulmonary Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Pulmonary Drugs Market 2016-2020, by Region, in USD Million
Table Global Pulmonary Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Pulmonary Drugs Market 2016-2020, by Region, in Volume
Table Global Pulmonary Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Pulmonary Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Pulmonary Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Pulmonary Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Pulmonary Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Pulmonary Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Pulmonary Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Pulmonary Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Pulmonary Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Pulmonary Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Pulmonary Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Pulmonary Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Pulmonary Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Pulmonary Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Pulmonary Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Pulmonary Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Pulmonary Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Pulmonary Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Pulmonary Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Pulmonary Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Pulmonary Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Pulmonary Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Pulmonary Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.